Associate Professor of Otolaryngology
University of Pittsburgh School of Medicine
Pittsburgh, PA, United States
Noel Jabbour, MD is an associate professor of pediatric otolaryngology at the University of Pittsburgh / Children's Hospital of Pittsburgh of UPMC. In addition to general pediatric otolaryngology, Dr. Jabbour provides subspecialty clinical care for children with velopharyngeal insufficiency, cleft palate, vascular anomalies of the head and neck, and congenital ear anomalies, including microtia and aural atresia.
He is a graduate of Wheaton College (IL) and the University of Pittsburgh School of Medicine. He completed his residency in otolaryngology at the University of Minnesota and his pediatric otolaryngology fellowship at Vanderbilt University. He earned a Masters of Science in Medical Education at the University of Pittsburgh and serves as the Program Director for the Otolaryngology--Head and Neck Surgery Residency Progtram at UPMC Pittsburgh.
Second Victims in Otolaryngology: Protecting Yourself From a Silent Epidemic
Saturday, September 28, 2024
5:00 PM – 5:50 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Sunday, September 29, 2024
1:06 PM – 1:12 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Monday, September 30, 2024
9:36 AM – 9:42 AM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Randomized Controlled Trial Using Patient-Specific 3D-Printed Model for Mastoidectomy Preparation
Monday, September 30, 2024
10:18 AM – 10:24 AM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Modern Presurgical Planning: Practical Uses for AR/VR and 3D-Printing
Tuesday, October 1, 2024
12:30 PM – 1:30 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.